3646 results for «678»

Filter By

3646 results

M-TEER for primary mitral regurgitation

08 Feb 2025 – From PCR Tokyo Valves 2025

In this PCR Tokyo Valves 2025 session on M-TEER for primary mitral regurgitation, gain valuable insights starting with an overview of current TEER devices. Benefit from four case studies that highlight the features of these devices, explore strategies to prevent mitral regurgitation recurrence post-TEER, and delve...

M-TEER for primary mitral regurgitation

M-TEER around the world

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore the latest insights and advancements in the field of Mitral Transcatheter Edge-to-Edge Repair (M-TEER) from around the world. Discover a new anatomical risk score for predicting procedural outcomes, two-year outcomes from the MiCLASP study, the impact of regurgitant volume to left atrial volume ratio on...

M-TEER around the world

M-TEER difficult situation: small mitral valves, P2 prolapse & leaflet degeneration

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore a series of challenging cases in Mitral Transcatheter Edge-to-Edge Repair (M-TEER), highlighting the versatility and adaptability of this technique. Discover how M-TEER can be successfully applied in patients with extremely small mitral valves, P2 prolapse supported by chordae from the posterior papillary muscle, wide prolapse...

M-TEER difficult situation: small mitral valves, P2 prolapse & leaflet degeneration

TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke

08 Feb 2025 – From PCR Tokyo Valves 2025

Gain valuable insights into the management of complications associated with Transcatheter Aortic Valve Implantation (TAVI). Discover the latest evidence on hemolytic anemia, the predictive value of the hemoglobin to creatinine ratio, outcomes of transcarotid TAVI, a case study on prosthetic valve endocarditis, the role of diastolic...

TAVI complications: hemolytic anemia, prosthetic valve endocarditis & stroke

Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease (WARRIOR)

31 Mar 2025

Nicola Ryan provides her take on the WARRIOR trial which was presented by Eileen Handberg at ACC.25 in Chicago.

The manuscript for this trial has not been published and all assumptions are based upon the presentation.

Nicola Ryan

Author

Nicola Ryan
Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease

Critical reflection on effective life-long learning – interventional cardiologists in pandemic times

17 Dec 2020

Because of the current COVID-19 environment with an exponential development of ‘digital format of postgraduate learning events’, often on the same topics, it seems essential to remember the foundation of effective post graduate learning in the field of medicine, and how we...

Interventional cardiologists in pandemic times
Didn’t find what you were looking for?